Navigation Links
Life Technologies Announces First Quarter 2013 Results
Date:5/2/2013

les, and Bioproduction.  Japan growth was primarily due to Ion Torrent and Bioproduction sales, offset by lower sales from government stimulus programs that took place in the same period last year.

OutlookThe Company anticipates revenue in the range of $950 million to $955 million and non-GAAP diluted earnings per share in the range of $0.94 to $0.97 for the quarter ending June 30, 2013, due to the impact from the fluctuations in currency rates, and the timing of operating expenses and larger deals compared to the guidance provided on February 4, 2013. Based on March 31, 2013 rates, currency is expected to have a negative impact of $62 million to revenue and a negative $0.15 impact to non-GAAP EPS for the full year.

Conference CallsGiven the recent announcement that Life Technologies and Thermo Fisher have entered into a definitive merger agreement under which Thermo Fisher will acquire all of the outstanding shares of Life Technologies for $76.00 per share in cash, the Company will no longer hold conference calls for its quarterly and annual earnings. The transaction, which is expected to close early in 2014, is subject to a Life shareholder vote and satisfying customary closing conditions, including regulatory approvals.

About Life Technologies Life Technologies Corporation (NASDAQ:  LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions are secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... neutral. That is, most of the atoms in ... electrons in the outer parts of atoms equals the ... As one or more electrons are plucked away from ... positive pull from the nucleus. This enhanced pull, ... those electrons are less vulnerable to the distractions of ...
(Date:7/18/2014)... July 18, 2014 Global biotechnology ... US offices in Cambridge, MA, announces the launch ... and Software product that leverages the power of ... Illumina® MiSeq sequencing platform. The assay and software ... Hospital of Philadelphia (CHOP) and will include a ...
(Date:7/18/2014)... 18, 2014 The International Wheat Genome Sequencing ... a draft sequence of the bread wheat genome. The ... and evolution of the large, complex genome of the ... genetic blueprint is an invaluable resource to plant science ... at their disposal a set of tools enabling them ...
(Date:7/17/2014)... 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the second quarter of 2014 on Thursday, ... The Company will host a conference call at ... which Vanda management will discuss the second quarter 2014 ...
Breaking Biology Technology:Highly charged ions 2Highly charged ions 3Highly charged ions 4Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2
... NPSP ) announced today that it has commenced,a ... outstanding 3.0% Convertible,Notes due 2008. The tender offer will ... extended. The tender offer, which is described,fully in an ... is not,subject to the receipt of any minimum amount ...
... BSX ) today announced that the Company,s Board ... Mr. Elliott, 58, is Chairman of the Board of ... Chief Executive Officer of,Zimmer from 2001 to 2007 and ... and director experience in medical devices,orthopaedics and other industries. ...
... 6 Resource Optimization &,Innovation (ROi), a ... Sisters of Mercy Health System, has signed ... purchasing Elekta,s innovative cancer treatment,solutions. (Logo: ... agreement, Mercy will offer its members the ...
Cached Biology Technology:NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 2NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 3NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008 4Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 2Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 3Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions 2
(Date:7/21/2014)... A new study in mice reveals that mesenchymal ... resistance exercise. , By injecting MSCs into mouse ... (similar to the lengthening contractions performed during resistance training ... were able to increase the rate of repair and ... the exercising mice. , The findings, described in ...
(Date:7/21/2014)... full of high-fat foods cause you to lose your ... State University neuroscientists says so, and it has researchers ... impact a whole range of human functions that were ... , "This opens up a lot of possibilities for ... Thiebaud, who led the study examining how high-fat foods ...
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
Breaking Biology News(10 mins):Stem cells aid muscle repair and strengthening after resistance exercise 2New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2
... Oct. 1, 2013  Pfenex Inc. today announced that the ... Biomedical Advanced Research and Development Authority (BARDA), has modified ... with the existing Pfenex contractual relationship begun in July, ... funding to support the development of a next generation ...
... October 1, 2013 -- Resveratrol, a naturally occurring polyphenol ... peanuts, and found in red wine, has been touted ... antioxidant properties. This has been supported by some experimental ... new study using two multiple sclerosis (MS) models published ...
... , Sept. 30, 2013 /PRNewswire-iReach/ -- Clinilabs, a ... drug development services to industry, announced today that they ... an investigational medication for Type 2 Diabetes Mellitus.  The ... tolerability of multiple daily doses of the investigational medication ...
Cached Biology News:Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 3Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication 2
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... H2OBIT is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... ,A robotic arm rapidly transfers a basket ... temperature ramping times that are considerably faster than ...
... used gasketed gel trays. Turn the tray 90 degrees ... back and run the gel - its as simple ... tray is UV transparent. Each tray accommodates two comb ... one in the center. This allows you the option ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: